BioCentury
ARTICLE | Company News

Ligon Discovery, Bayer deal

October 4, 2010 7:00 AM UTC

Bayer's Bayer Schering Pharma AG subsidiary will use Ligon's proprietary Small Molecule Microarray (SMM) screening technology to discover compounds against undisclosed targets to treat oncology and co...